Modern Diagnostic IPO (SME)
Modern Diagnostic & Research Centre Ltd. is launching a Book-Built SME IPO of Rs. 36.89 crore, entirely a fresh issue of 40,99,200 equity shares.
The IPO opens on December 31, 2025 and closes on January 2, 2026.
The allotment is expected on January 5, 2026, and the tentative listing on January 7, 2026, on BSE SME.
The price band is Rs. 85 to Rs. 90 per share.
The lot size is 1,600 shares.
As the minimum retail application requires 2 lots (3,200 shares), the minimum retail investment is Rs. 2,88,000 at the upper price.
Registrar: MUFG Intime India Pvt. Ltd.
Market Maker: Spread X Securities Pvt. Ltd.
| Final Subscription Tally Net Size – Rs.35.00 Crore Q-50%,NII-15% RII-35% Op-31 Dec Close- 2 Jan All-5 Jan Li-7 Jan |
||||
| QIB | NII x | RII x | Total x | Applications |
| 193.51 | 519.38 | 342.46 | 350.49 | 189518 |
| Applications- Q-106,NII-43520, RII-145889 GMP Op-10-17-10 End-17 |
||||
🕗 Last Update: 7 January 2026, 6.00 AM
👉 GMP | Reviews | Subscription | Allotment
👉 Chanakya Grey Market Intelligence – 8 PM Edition | News Crux |
👉 Power Calls | Breakout Stocks | Coffee Can Portfolio |
IPO Details
| Particulars | Details |
|---|---|
| IPO Dates | Dec 31, 2025 – Jan 2, 2026 |
| Listing | BSE SME |
| Face Value | Rs. 10 per share |
| Price Band | Rs. 85 to Rs. 90 |
| Lot Size | 1,600 shares |
| Issue Size | 40,99,200 shares (Rs. 36.89 Cr) |
| Fresh Issue | Entirely Fresh |
| Market Maker Portion | 2,06,400 shares (Rs. 2.00 Cr) |
| Net Offer to Public | 38,92,800 shares (Rs. 35.00 Cr) |
| Pre-Issue Shares | 1,10,00,000 |
| Post-Issue Shares | 1,50,99,200 |
| Market Cap (Pre-IPO) | Rs. 135.89 Cr |
IPO Timeline (Tentative)
| Event | Date |
|---|---|
| IPO Open | Wed, Dec 31, 2025 |
| IPO Close | Fri, Jan 2, 2026 |
| Allotment | Mon, Jan 5, 2026 |
| Refunds | Tue, Jan 6, 2026 |
| Shares in Demat | Tue, Jan 6, 2026 |
| Listing Date | Wed, Jan 7, 2026 |
| UPI Cut-off | 5 PM, Jan 2, 2026 |
Reservation Structure
| Investor Category | Shares |
|---|---|
| Market Maker | 2,06,400 |
| QIB | Not more than 50% of Net Issue |
| NII (HNI) | Not less than 15% of Net Issue |
| Retail | Not less than 35% of Net Issue |
IPO Lot Size
| Category | Lots | Shares | Amount (Rs.) |
|---|---|---|---|
| Retail (Min–Max) | 2 | 3,200 | 2,88,000 |
| S-HNI (Min) | 3 | 4,800 | 4,32,000 |
| S-HNI (Max) | 6 | 9,600 | 8,64,000 |
| B-HNI (Min) | 7 | 11,200 | 10,08,000 |
Company Financials (Rs. in Crore)
| Period | 30-Sep-24 | FY24 | FY23 | FY22 |
|---|---|---|---|---|
| Assets | 57.79 | 49.49 | 36.54 | 48.70 |
| Total Income | 40.33 | 68.67 | 56.61 | 60.58 |
| PAT | 4.96 | 5.79 | -5.73 | -1.45 |
| Net Worth | 16.71 | 11.76 | 5.96 | 11.70 |
| Reserves & Surplus | 15.71 | 10.76 | 4.96 | 10.70 |
| Borrowings | 21.13 | 20.46 | 15.31 | 20.40 |
Growth Snapshot
Based on available financials, the company has returned to profitability in FY24 after reporting losses in FY22 and FY23. PAT improved to Rs. 5.79 crore in FY24, indicating recovery ahead of the IPO. Asset base and income levels reflect a stabilising operating profile, though borrowings remain elevated and require monitoring.
Key Performance Indicators (As of FY24)
| KPI | Value |
|---|---|
| ROE | 65.40% |
| ROCE | 25.58% |
| Debt / Equity | 1.74 |
| RoNW | 49.28% |
| PAT Margin | 8.63% |
| Price to Book Value | 0.77 |
| EPS (Pre / Post) | Rs. 5.27 / Rs. 6.56 |
| P/E (Pre / Post) | 17.08x / 13.71x |
About the Company
Incorporated in 1985, Modern Diagnostic & Research Centre Ltd. (MDRC) is a diagnostic chain in India offering a comprehensive range of pathology and radiology services.
The company provides diagnostic testing, home sample collection, online reporting and customised test packages for hospitals, institutions and individual patients.
MDRC operates 21 centres (17 laboratories and 4 diagnostic centres) across 8 states, offering services such as ultrasound, CT, MRI, X-ray, ECG, PFT and specialised diagnostic testing for cardiac and neuro care.
As on February 28, 2025, the company had 570 employees, including consultants and doctors.
Competitive Strengths
-
Experienced promoter and management team
-
Comprehensive diagnostics offering under one platform
-
Focus on quality standards and customer service
-
Centralised IT and reporting infrastructure
-
Wide geographic footprint across multiple states
Promoters
The promoters of the company are Mr. Devendra Singh Yadav, Mrs. Deepali Yadav, Mrs. Asha Yadav and Mr. Jitendra Singh.
Company Contact
IPO Lead Manager(s)
Beeline Capital Advisors Pvt. Ltd.
- Grade A (Trusted Banker)
✔ Success ≥ 80% AND Avg Listing Gain > 8%
IPO Registrar
MUFG Intime India Pvt. Ltd.
📞 +91-22-4918 6270
✉️ moderndiagnostic.smeipo@in.mpms.mufg.com
🌐 https://in.mpms.mufg.com
Chanakya IPO Review
Modern Diagnostic & Research Centre operates in the healthcare diagnostics space with a long operating history and diversified service offerings across pathology and radiology. The company has demonstrated a turnaround in profitability in FY24 after losses in earlier years, which is a positive development ahead of the IPO.
Chanakya View
Suitable for medium-risk investors. Key monitorables include sustainability of profitability, debt levels and working capital management. Listing performance will depend on subscription response, SME market sentiment and confidence in earnings stability post-IPO.
Quicklinks
- Market Analysis by Nagaraj Shetti
- Stock Market today by Vaishali Parekh
- Analysis by Kotak Securities
- Market Analysis by HDFC Securities
- Technical Analysis by Kotak Securities
- Technical Analysis by Samco Securities
- Reliance, Target & Stoploss
- Gold Analysis
- FII buy-Sell
- Technical Analysis
- Calls for the Day
- Currency Analysis
Disclaimer
This coverage is for informational and educational purposes. Chanakya Ni Pothi does not deal in Grey Market Premiums or recommend investments based on GMP data. Please consult your SEBI-registered investment advisor.

